Trial no.:
|
PACTR202408721579454 |
Date of Approval:
|
12/08/2024 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Insulin sensitivity and testosterone hormone response to aerobic exercise versus added sugar elimination in PCO women |
Official scientific title |
Insulin sensitivity and testosterone hormone response to aerobic exercise versus added sugar elimination in PCO women |
Brief summary describing the background
and objectives of the trial
|
Ketosis (KD) can enhance various anthropometric and biochemical parameters in patients with polycystic ovary syndrome (PCOS), including luteinizing hormone (LH), follicle-stimulating hormone (FSH), sex hormone-binding globulin (SHBG), insulin sensitivity, and HOMA index. It also decreases androgenic production and unregulated estrogen production, improving the LH/FSH ratio. Low-calorie ketogenic diets (VLCKD) are effective short-term interventions for weight loss and metabolic profile improvement. In PCOS, hyperandrogenic environments promote post-pubertal neuroendocrine dysfunction, leading to increased luteinizing hormone (LH) release and decreased FSH release. Insulin plays a key role in metabolic homeostasis, ion and amino acid transport, cell proliferation, differentiation, and death. Insulin resistance is a mechanistic factor in cardiovascular risk factors and has been identified as an independent factor for CV disease incidence. Exercise training can improve sympathetic nervous system control and reduce sympathetic activity in conditions characterized by insulin resistance.
The aim ot the trial is to assess the insulin sensitivity response and testosterone hormone to aerobic exercise versus added sugar elimination in PCO women. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Obstetrics and Gynecology |
Sub-Disease(s) or condition(s) being studied |
polycystic ovary syndrome |
Purpose of the trial |
Treatment: Devices |
Anticipated trial start date |
25/10/2024 |
Actual trial start date |
|
Anticipated date of last follow up |
22/02/2025 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
|
Recruitment status |
Not yet recruiting |
Publication URL |
|
|